Muscarinic receptor subtypes in human iris-ciliary body measured by immunoprecipitation
- PMID: 9191607
Muscarinic receptor subtypes in human iris-ciliary body measured by immunoprecipitation
Abstract
Purpose: To determine the relative levels of the five muscarinic receptor subtypes in the anterior segment of the human eye.
Methods: Antisera selective for each of the five muscarinic receptor proteins were incubated with [3H]-QNB bound receptors solubilized from human iris sphincter, ciliary muscle, and ciliary processes. Precipitation of the radiolabeled receptor-antibody complexes and scintillation counting enabled quantitation of the subtypes in the various tissues. Reverse transcription-polymerase chain reaction was performed on the tissues and cultured smooth muscle cells derived from them.
Results: Approximately 60% to 75% of the muscarinic receptors in the human iris sphincter and ciliary body are the m3 subtype. Lower levels (5% to 10%) of the m2 and m4 receptors are present in these tissues. The m1 receptor (7%) was detected in the ciliary processes and iris sphincter and the m5 receptor (5%), which is usually found only in the central nervous system, was present in the iris sphincter.
Conclusions: The m3 subtype is the predominant muscarinic receptor in the anterior segment of the human eye. The extensive heterogeneity of muscarinic receptors makes it difficult to predict whether subtype-selective drugs will have an improved efficacy and side-effect profile.
Similar articles
-
M3-muscarinic receptor subtype predominates in the bovine iris sphincter smooth muscle and ciliary processes.Invest Ophthalmol Vis Sci. 1990 Mar 1;31(3):590-3. Invest Ophthalmol Vis Sci. 1990. PMID: 1690689
-
Expression of muscarinic receptor subtype mRNA in the human ciliary muscle.Invest Ophthalmol Vis Sci. 1995 Jul;36(8):1645-57. Invest Ophthalmol Vis Sci. 1995. PMID: 7541396
-
Development of an antiserum against m3 muscarinic receptors: distribution of m3 receptors in rat tissues and clonal cell lines.Mol Pharmacol. 1991 Nov;40(5):783-9. Mol Pharmacol. 1991. PMID: 1944243
-
Muscarinic receptor subtypes in the alimentary tract.J Physiol Pharmacol. 2009 Mar;60(1):3-21. J Physiol Pharmacol. 2009. PMID: 19439804 Review.
-
The muscarinic receptor subtypes in human blood vessels.Therapie. 2001 May-Jun;56(3):223-6. Therapie. 2001. PMID: 11475798 Review.
Cited by
-
Use of M1-M5 muscarinic receptor knockout mice as novel tools to delineate the physiological roles of the muscarinic cholinergic system.Neurochem Res. 2003 Apr;28(3-4):437-42. doi: 10.1023/a:1022844517200. Neurochem Res. 2003. PMID: 12675128 Review.
-
First-in-man study to investigate safety, pharmacokinetics and exploratory pharmacodynamics of HTL0018318, a novel M1 -receptor partial agonist for the treatment of dementias.Br J Clin Pharmacol. 2021 Jul;87(7):2945-2955. doi: 10.1111/bcp.14710. Epub 2021 Feb 5. Br J Clin Pharmacol. 2021. PMID: 33351971 Free PMC article. Clinical Trial.
-
Ocular Cyclopentolate: A Mini Review Concerning Its Benefits and Risks.Clin Ophthalmol. 2022 Nov 15;16:3753-3762. doi: 10.2147/OPTH.S388982. eCollection 2022. Clin Ophthalmol. 2022. PMID: 36411874 Free PMC article. Review.
-
Effects of adrenergic and cholinergic antagonists on diameter of nasolacrimal drainage system.Graefes Arch Clin Exp Ophthalmol. 2007 Dec;245(12):1843-50. doi: 10.1007/s00417-007-0615-4. Epub 2007 Jun 20. Graefes Arch Clin Exp Ophthalmol. 2007. PMID: 17579880
-
Pilocarpine-induced dilation of Schlemm's canal and prevention of lumen collapse at elevated intraocular pressures in living mice visualized by OCT.Invest Ophthalmol Vis Sci. 2014 Mar 4;55(6):3737-46. doi: 10.1167/iovs.13-13700. Invest Ophthalmol Vis Sci. 2014. PMID: 24595384 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources